​

Hinge Health Stock (NYSE:HNGE)

ForecastRevenueOwnershipFinancialsChartTranscripts
Hinge Health by TradingView

Previous Close

$43.24

52W Range

$30.08 - $62.18

50D Avg

$41.68

200D Avg

$46.94

Market Cap

$3.49B

Avg Vol (3M)

$1.22M

Beta

1.81

Div Yield

-

HNGE Company Profile

Hinge Health, Inc. develops health care software for joint and muscle health. The company designs its platform to address a musculoskeletal care, acute injury, chronic pain, and post-surgical rehabilitation. It also provides various administrative and operations support services. The company was founded in 2012 and is headquartered in San Francisco, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NYSE

ADR

-

Country

US

Employees

1,514

IPO Date

May 22, 2025

Website

HNGE Performance

Revenue Breakdown

Revenue Breakdown by Product/Service

Product/ServiceDec 25
Reportable Segment$587.86M

Fiscal year ends in Dec 25 | Currency in USD

HNGE Financial Summary

Dec 25Dec 24Dec 23
Revenue$587.86M$390.40M$292.73M
Operating Income$-546.37M$-24.43M$-130.51M
Net Income$-528.26M$-11.93M$-108.14M
EBITDA$-541.24M$-5.31M$-102.92M
Basic EPS$-5.36$-0.15$-1.39
Diluted EPS$-5.19$-0.15$-1.39

Fiscal year ends in Dec 25 | Currency in USD

Latest Earnings Call Transcripts

Q4 25Feb 10, 26 | 4:30 PM
Q3 25Nov 04, 25 | 4:30 PM

Peer Comparison

TickerCompany
VKTXViking Therapeutics, Inc.
CRNXCrinetics Pharmaceuticals, Inc.
OSCROscar Health, Inc.
PRAXPraxis Precision Medicines, Inc.
DYNDyne Therapeutics, Inc.
WGSGeneDx Holdings Corp.
AKROAkero Therapeutics, Inc.
IMVTImmunovant, Inc.
LNTHLantheus Holdings, Inc.